[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Pr. Nicolas GIRERD\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":123},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,38,60,81,106],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100555266","pathway-of-dyspneic-patient-in-emergency-in-france-100555266",false,"NCT06509854","PAthwAy of Dyspneic patIent in Emergency in France","Fr-PArADIse","Inclusion Criteria:\n\n* Man or women aged 18 years and older.\n* Patients with acute dyspnea managed by a medical emergency team at the investigator centers between 2010 and 2021.\n\nExclusion Criteria:\n\n\\- Cardiorespiratory arrest before emergency department management.","ALL","18 Years",{"count":19,"type":20},89700,"ESTIMATED","OBSERVATIONAL","This observational retrospective multi-center study focuses on patients treated for acute dyspnea by emergency medical teams. The primary objective is to identify factors associated with the risk of mortality and rehospitalization in these patients. This evaluation will be conducted both overall and within specific subgroups of interest, including gender (men\u002Fwomen), age categories, mode of admission, and comorbidities.",[24],"Acute Dyspnea","NOT_YET_RECRUITING","2024-07-18",{"date":28,"type":29},"2024-07-22","ACTUAL",{"date":31,"type":20},"2024-09-30",{"date":33,"type":20},"2031-09-30",{"name":35,"class":36},"Pr. Nicolas GIRERD","OTHER",4,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":47,"conditions":48,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},"100542131","patient-treatment-analysis-hospital-and-wide-ranging-out-of-hospital-care-assessment-yields-insights-into-heart-failure-outcomes-100542131","NCT06338878","PAtient Treatment Analysis: Hospital and Wide-ranging Out-of-hospital Care Assessment Yields Insights Into Heart Failure Outcomes","PATHWAY-HF","Inclusion Criteria:\n\n* Man or women ≥ 18 years\n* Patients hospitalized for cardiac decompensation (ESC 2016 and 2021 criteria)\n\nExclusion Criteria:\n\n* Patient expressing refusal to participate in research\n* Patient who is a minor or under administrative protection\n* Pregnant women\n* Patient with ventricular assistance\n* Patient with congenital heart disease",{"count":46,"type":20},1000,"This is a monocentric cohort study conducted in the cardiology department of Nancy hospital. The main purpose of the study is to document the global management strategy of patients hospitalized for heart failure and evaluate the association between patient's care and post-hospitalization outcome.",[49],"Heart Failure","RECRUITING","2024-03-27",{"date":53,"type":29},"2024-04-01",{"date":55,"type":29},"2024-03-01",{"date":57,"type":20},"2029-01",{"name":35,"class":36},1,{"id":61,"slug":62,"hasResults":11,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":66,"eligibilityCriteria":67,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":68,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":70,"conditions":71,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":59},"100534144","pathway-of-dyspneic-patient-in-emergency-in-the-north-east-region-north-east-paradise-100534144","NCT06235008","PAthwAy of Dyspneic patIent in Emergency in the North-east Region (North-East PArADIsE)","PAthwAy of Dyspneic patIent in Emergency in the North-east Region","N_E_PARADISE","Inclusion Criteria:\n\n* Man or women ≥ 18 years\n* Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy, CHR Metz-Thionville and CH d'Epinal.\n\nExclusion Criteria:\n\n* Cardiorespiratory arrest before medical management by the Emergency Department team\n* Adults under legal protection",{"count":69,"type":20},75000,"This is an observational retrospective multi-center study in patients managed for acute dyspnea by Emergency department medical team.\n\nThe main aim of the study is to evaluate factors associated with mortality risks in patients managed for acute dyspnea by an Emergency department medical team, overall, as well as in subgroups of interest (male\u002Ffemale, age categories, mode of admission and comorbidities).",[72],"Dyspnea","2024-01-22",{"date":75,"type":29},"2024-01-31",{"date":77,"type":20},"2024-03-31",{"date":79,"type":20},"2030-09-30",{"name":35,"class":36},{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":91,"phases":92,"briefSummary":94,"conditions":95,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},"100446108","chronic-heart-failure---congestion-evaluation-100446108","NCT05089149","Chronic Heart Failure - COngestion eValuation","Évaluation de la Congestion en Ambulatoire Chez Les Patients Atteints d'Insuffisance Cardiaque Chronique. CHF-COV (Chronic Heart Failure - COngestion eValuation)","CHF-COV","Inclusion Criteria:\n\n* Patients with chronic acute heart failure admitted in hospital for scheduled day hospitalization or consultation\n* Age ≥18 years\n* Patients having received complete information regarding the study design and having signed their informed consent form.\n* Patient affiliated to or beneficiary of a social security scheme.\n\nExclusion Criteria:\n\n* Comorbidity for which the life expectancy is ≤ 3 months\n* Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate \\\u003C15 ml\u002Fmin\u002Fm2 at inclusion.\n* History of lobectomy or pneumonectomy lung surgery\n* Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.\n* Pregnant woman, parturient or nursing mother\n* Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)\n* Adult person who is unable to give consent\n* Person deprived of liberty by a judicial or administrative decision,\n* Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code.",{"count":90,"type":20},200,"INTERVENTIONAL",[93],"NA","Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of hospitalization for HF. Furthermore, congestive signs identified in asymptomatic patients are associated with the risk of developing symptomatic HF. The literature supports a multi-modality \u002F integrative evaluation of congestion, combining clinical examination, laboratory results and ultrasound evaluation.\n\nThe main objective of the CHF-COV study is to identify congestion markers (clinical, biological and ultrasound) quantified during a consultation or day hospitalization for the monitoring of chronic HF that are associated with the risk of all-cause death or hospitalization for acute HF within 24 months after day hospitalization.",[96],"Chronic Heart Failure","2023-06-02",{"date":99,"type":29},"2023-06-05",{"date":101,"type":29},"2021-12-14",{"date":103,"type":20},"2029-06-14",{"name":35,"class":36},2,{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":114,"targetDuration":4,"studyType":91,"phases":115,"briefSummary":116,"conditions":117,"keywords":4,"overallStatus":50,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":119,"startDateStruct":120,"completionDateStruct":121,"leadSponsor":122,"locationsCount":59},"100446109","chf-cov-reduced-chronic-heart-failure-with-reduced-ejection-fraction---congestion-evaluation-100446109","NCT05089162","CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)","Evaluation de la Congestion en Hospitalisation de Jour Pour un Bilan d'Insuffisance Cardiaque Chronique à Fraction d'éjection altérée ou modérément altérée CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)","CHF-COVReduced","Inclusion Criteria:\n\n* Patients with chronic acute heart failure with reduced ventricular ejection fraction admitted in hospital for scheduled day hospitalization or in consultation\n* Patient with altered (left ventricular ejection fraction \\\u003C40%) and moderately altered (left ventricular ejection fraction between 40 and 50%) left ventricular ejection fraction\n* Age ≥18 years\n* Patients having received complete information regarding the study design and having signed their informed consent form.\n* Patient affiliated to or beneficiary of a social security scheme.\n\nExclusion Criteria:\n\n* Comorbidity for which the life expectancy is ≤ 3 months\n* Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular filtration rate \\\u003C15 ml\u002Fmin\u002Fm2 at inclusion.\n* History of lobectomy or pneumonectomy lung surgery\n* Severe pulmonary or pleural pathology preventing reliable acquisition of lung ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.\n* Pregnant woman, parturient or nursing mother\n* Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice)\n* Adult person who is unable to give consent\n* Person deprived of liberty by a judicial or administrative decision,\n* Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of the Public Health Code.",{"count":90,"type":20},[93],"Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of hospitalization for HF. Furthermore, congestive signs identified in asymptomatic patients are associated with the risk of developing symptomatic HF. The literature supports a multi-modality \u002F integrative evaluation of congestion, combining clinical examination, laboratory results and ultrasound evaluation.\n\nThe main objective of the CHF-COVReduced study is to identify congestion markers (clinical, biological and ultrasound) quantified during a consultation or day hospitalization for the monitoring of chronic HF with reduced left ventricular ejection fraction that are associated with the risk of all-cause death, hospitalization for acute HF or IV diuretics injection in a day hospital.",[96,118],"Reduced Ventricular Ejection Fraction",{"date":99,"type":29},{"date":101,"type":29},{"date":103,"type":20},{"name":35,"class":36},""]